Correlation Between INtRON Biotechnology and E Investment

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both INtRON Biotechnology and E Investment at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INtRON Biotechnology and E Investment into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iNtRON Biotechnology and E Investment Development, you can compare the effects of market volatilities on INtRON Biotechnology and E Investment and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INtRON Biotechnology with a short position of E Investment. Check out your portfolio center. Please also check ongoing floating volatility patterns of INtRON Biotechnology and E Investment.

Diversification Opportunities for INtRON Biotechnology and E Investment

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between INtRON and 093230 is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding iNtRON Biotechnology and E Investment Development in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on E Investment Development and INtRON Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iNtRON Biotechnology are associated (or correlated) with E Investment. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of E Investment Development has no effect on the direction of INtRON Biotechnology i.e., INtRON Biotechnology and E Investment go up and down completely randomly.

Pair Corralation between INtRON Biotechnology and E Investment

Assuming the 90 days trading horizon iNtRON Biotechnology is expected to under-perform the E Investment. But the stock apears to be less risky and, when comparing its historical volatility, iNtRON Biotechnology is 1.01 times less risky than E Investment. The stock trades about -0.01 of its potential returns per unit of risk. The E Investment Development is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  90,700  in E Investment Development on October 24, 2024 and sell it today you would earn a total of  48,500  from holding E Investment Development or generate 53.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.79%
ValuesDaily Returns

iNtRON Biotechnology  vs.  E Investment Development

 Performance 
       Timeline  
iNtRON Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iNtRON Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, INtRON Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
E Investment Development 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days E Investment Development has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, E Investment is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

INtRON Biotechnology and E Investment Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with INtRON Biotechnology and E Investment

The main advantage of trading using opposite INtRON Biotechnology and E Investment positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INtRON Biotechnology position performs unexpectedly, E Investment can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in E Investment will offset losses from the drop in E Investment's long position.
The idea behind iNtRON Biotechnology and E Investment Development pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings